Status
Conditions
Treatments
About
The aim of the study is to investigate the effect of losartan (50mg, single dose) on social reward
Full description
In a double-blind, between-subject, placebo-controlled design the effects of a single dose of losartan (50mg) on social reward in healthy participants will be examined. 90 minutes after subjects administrate 50mg losartan or placebo, participants will undergo a social incentive delay task. Neural activity will be assessed by the acquisition of functional magnetic resonance imaging (fMRI) data.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
90 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Weihua Zhao, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal